Results 221 to 230 of about 49,575 (291)

SPAN-C: Results of a Phase II Clinical Trial of Stereotactic Body Radiotherapy in Pancreatic Ductal Adenocarcinoma. [PDF]

J Med Imaging Radiat Oncol
Chan J, Kneebone A, Metz G, Booth J, Shepherd M, Kwong C, Brown C, Norton I, Clarke S, Diakos C, Pavlakis N, Mittal A, Samra J, Hruby G.   +13 more
europepmc   +1 more source

Comprehensive end-to-end dosimetry audit for stereotactic body radiotherapy in spine, lung, and soft tissue. [PDF]

J Appl Clin Med Phys
Shaw M, Alves A, Lye J, Lehmann J, Kadeer F, Beveridge S, Hardcastle N, Geso M, Brown R.   +8 more
europepmc   +1 more source

The effect of increasing the prescribed dose in stereotactic body radiotherapy for primary lung cancer without lymph node metastasis

Kosuke Morishima, Hideomi Yamashita, Yosuke Miki, Subaru Sawayanagi, Ryosuke Takenaka, Atsuto Katano   +5 more
openalex   +1 more source

Impact of four-dimensional computed tomography phase number on target coverage of four-dimensional robustly optimized lung stereotactic body radiotherapy. [PDF]

Sci Rep
Yagihashi T, Inoue T, Yamanaka M, Shiba S, Yamano A, Sato N, Minagawa Y, Omura M.   +7 more
europepmc   +1 more source

Dosimetric comparison of IMRT, VMAT, and hybrid techniques in stereotactic body radiotherapy for adrenal metastases. [PDF]

Sci Rep
Aslan D, Aksozen MT.
europepmc   +1 more source

Recent Advances and Challenges in Stereotactic Body Radiotherapy

Technology in Cancer Research & Treatment
Atsuto Katano MD, PhD, Masanari Minamitani MD, PhD, Shingo Ohira PhD, Hideomi Yamashita MD, PhD   +3 more
doaj   +1 more source

Real-World Clinical Outcomes and Biopsy Patterns of Older Patients with Unresected Non-Small-Cell Lung Cancer Treated with Primary Stereotactic Body Radiotherapy. [PDF]

J Clin Med
Rai P, Zhang S, Song Y, Gao C, Jiang A, Li J, Jiang P, Signorovitch J, Arunachalam A, Song A, Samkari A, Daly ME.   +11 more
europepmc   +1 more source

Assessment of toxicity in patients with ultra-central thoracic tumours treated with stereotactic body radiotherapy with a dose of 50 Gy in 5 fractions. [PDF]

Rep Pract Oncol Radiother
Asso RN, Kopek N, Duclos M, Abdulkarim B, Connell T, Perna M, Faria SL.   +6 more
europepmc   +1 more source

Evaluation of loco-regional recurrences using deformable image registration after isotoxic high dose stereotactic body radiotherapy in localised pancreatic cancer. [PDF]

Clin Transl Radiat Oncol
Manderlier M, Poeta S, Engelholm JL, Gulyban A, Van Laethem JL, Bouchart C.   +5 more
europepmc   +1 more source